Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP502757.RA8KVCkG2NvRqemyxMkF6N1i8Of648j3titxucuJO-jCE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP502757.RA8KVCkG2NvRqemyxMkF6N1i8Of648j3titxucuJO-jCE130_assertion type Assertion NP502757.RA8KVCkG2NvRqemyxMkF6N1i8Of648j3titxucuJO-jCE130_head.
- NP502757.RA8KVCkG2NvRqemyxMkF6N1i8Of648j3titxucuJO-jCE130_assertion description "[The authors conclude that a pVAX/PSA DNA vaccine can induce PSA-specific cellular immune responses in patients with hormone-refractory prostate cancer, thus emphasizing the potential for PSA as a target molecule for the immunotherapy of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP502757.RA8KVCkG2NvRqemyxMkF6N1i8Of648j3titxucuJO-jCE130_provenance.
- NP502757.RA8KVCkG2NvRqemyxMkF6N1i8Of648j3titxucuJO-jCE130_assertion evidence source_evidence_literature NP502757.RA8KVCkG2NvRqemyxMkF6N1i8Of648j3titxucuJO-jCE130_provenance.
- NP502757.RA8KVCkG2NvRqemyxMkF6N1i8Of648j3titxucuJO-jCE130_assertion SIO_000772 16000958 NP502757.RA8KVCkG2NvRqemyxMkF6N1i8Of648j3titxucuJO-jCE130_provenance.
- NP502757.RA8KVCkG2NvRqemyxMkF6N1i8Of648j3titxucuJO-jCE130_assertion wasDerivedFrom befree-2016 NP502757.RA8KVCkG2NvRqemyxMkF6N1i8Of648j3titxucuJO-jCE130_provenance.
- NP502757.RA8KVCkG2NvRqemyxMkF6N1i8Of648j3titxucuJO-jCE130_assertion wasGeneratedBy ECO_0000203 NP502757.RA8KVCkG2NvRqemyxMkF6N1i8Of648j3titxucuJO-jCE130_provenance.